SOLIGENIX, INC. business relationships
Companies named in SOLIGENIX, INC.’s 10-K filed 2026-03-31, and public companies whose annual reports name SOLIGENIX, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.0 / 10
- AI naming
- <1 / 100 Top 19% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in SOLIGENIX, INC.’s annual report 2
“We have entered into a collaboration with IDT Biologika GmbH ("IDT") to scale-up the formulation/filling process and continue development and validation of analytical methods established at IDT to advance the program.” SEC filing
“In October 2024, we established a partnership agreement with Sterling Pharma Solutions Limited ("Sterling") to optimize and implement a commercially viable, scalable production technology for synthetic hypericin.” SEC filing
Links are read automatically from public company filings, so every link carries the sentence it came from.
Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms